Atara Biotherapeutics, Inc. (ATRA) dividend history

ATRANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30

$7.70−0.23 (-2.90%)

Close on Nov 13, 2026Market cap $77.29MP/E –Yield –

Dividends

No dividend per share appears in Atara Biotherapeutics's annual filings since fiscal 2012.

Parsed from the XBRL in Atara Biotherapeutics's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-25 reverse split on Jun 20, 2024
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ATRA.

Revenue growth-97.4% · median -32.5%

Operating margin-343.6% · median -2503.4%

Net margin-368.6% · median -2419.4%

Advertisement
300 × 250

See a number that looks wrong?